DE60123074D1 - Modulation von gamma-secretase aktivität - Google Patents

Modulation von gamma-secretase aktivität

Info

Publication number
DE60123074D1
DE60123074D1 DE60123074T DE60123074T DE60123074D1 DE 60123074 D1 DE60123074 D1 DE 60123074D1 DE 60123074 T DE60123074 T DE 60123074T DE 60123074 T DE60123074 T DE 60123074T DE 60123074 D1 DE60123074 D1 DE 60123074D1
Authority
DE
Germany
Prior art keywords
app
gamma
secretase
assay
cells expressing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60123074T
Other languages
English (en)
Other versions
DE60123074T2 (de
DE60123074T3 (de
Inventor
Barbara Cordell
N Higaki
Mitchell Mutz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scios LLC
Original Assignee
Scios LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22754280&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60123074(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Scios LLC filed Critical Scios LLC
Publication of DE60123074D1 publication Critical patent/DE60123074D1/de
Publication of DE60123074T2 publication Critical patent/DE60123074T2/de
Application granted granted Critical
Publication of DE60123074T3 publication Critical patent/DE60123074T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Holo Graphy (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE60123074.4T 2000-05-11 2001-05-09 Modulation von gamma-secretase aktivität Expired - Lifetime DE60123074T3 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US20350600P 2000-05-11 2000-05-11
US203506P 2000-05-11
PCT/US2001/015089 WO2001085924A2 (en) 2000-05-11 2001-05-09 MODULATION OF η-SECRETASE ACTIVITY
EP01935260.8A EP1305406B2 (de) 2000-05-11 2001-05-09 Modulation von gamma-secretase aktivität

Publications (3)

Publication Number Publication Date
DE60123074D1 true DE60123074D1 (de) 2006-10-26
DE60123074T2 DE60123074T2 (de) 2007-03-01
DE60123074T3 DE60123074T3 (de) 2015-01-29

Family

ID=22754280

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60123074.4T Expired - Lifetime DE60123074T3 (de) 2000-05-11 2001-05-09 Modulation von gamma-secretase aktivität

Country Status (8)

Country Link
US (2) US6579689B2 (de)
EP (1) EP1305406B2 (de)
JP (1) JP2003532413A (de)
AT (1) ATE339496T1 (de)
AU (1) AU2001261368A1 (de)
DE (1) DE60123074T3 (de)
DK (1) DK1305406T4 (de)
WO (1) WO2001085924A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004505608A (ja) * 2000-04-03 2004-02-26 ブリストル−マイヤーズ　スクイブ　カンパニー 機能的に活性なガンマ−セクレターゼタンパク質複合体の単離およびその活性およびインヒビターの検出法
US20030022251A1 (en) * 2001-07-04 2003-01-30 Boehringer Ingelheim Pharma Kg Gamma-secretase in vitro screening assay
WO2003057165A2 (en) * 2002-01-04 2003-07-17 The Rockefeller University COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF AMYLOID-β PEPTIDE-RELATED DISORDERS
CN1319987C (zh) * 2002-04-24 2007-06-06 森启 γ－分泌酶抑制剂
AU2006203819A1 (en) * 2005-01-07 2006-07-13 Roskamp Research Llc Compounds for inhibiting beta-amyloid production and methods of identifying the compounds
EP2461673A4 (de) 2009-08-05 2013-08-07 Intra Cellular Therapies Inc Neue regulatorproteine und hemmer

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4372888A (en) † 1980-08-26 1983-02-08 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Nondenaturing zwitterionic detergents
CA2191924A1 (en) * 1995-12-05 1997-06-06 Kevin Felsenstein 5-amino-6-cyclohexyl-4-hydroxy-hexanamide derivatives as inhibitors of .beta.-amyloid protein production
GB9608657D0 (en) * 1996-04-26 1996-07-03 Smithkline Beecham Plc Novel treatment
WO1998015828A1 (en) 1996-10-07 1998-04-16 Scios Inc. Method to identify direct inhibitors of the beta-amyloid forming enzyme gamma-secretase
US6313268B1 (en) † 1998-10-16 2001-11-06 Vivian Y. H. Hook Secretases related to Alzheimer's dementia
DE19941039A1 (de) * 1999-08-28 2001-03-01 Boehringer Ingelheim Pharma gamma-Sekretase in vitro Testsystem
DE10000161A1 (de) * 2000-01-06 2001-07-19 Boehringer Ingelheim Pharma Verfahren zur Identifikation eines Proteaseinhibitors
JP2004505608A (ja) * 2000-04-03 2004-02-26 ブリストル−マイヤーズ　スクイブ　カンパニー 機能的に活性なガンマ−セクレターゼタンパク質複合体の単離およびその活性およびインヒビターの検出法

Also Published As

Publication number Publication date
DK1305406T4 (en) 2015-02-02
WO2001085924A3 (en) 2003-02-27
WO2001085924A2 (en) 2001-11-15
EP1305406B2 (de) 2014-11-12
DE60123074T2 (de) 2007-03-01
US20010055782A1 (en) 2001-12-27
DK1305406T3 (da) 2007-01-08
JP2003532413A (ja) 2003-11-05
AU2001261368A1 (en) 2001-11-20
US20030211559A1 (en) 2003-11-13
EP1305406B1 (de) 2006-09-13
EP1305406A2 (de) 2003-05-02
US6579689B2 (en) 2003-06-17
ATE339496T1 (de) 2006-10-15
DE60123074T3 (de) 2015-01-29

Similar Documents

Publication Publication Date Title
DK1210411T3 (da) Sammensætninger og fremgangsmåder til forbedret celledyrkning
HUP0301245A2 (hu) Eljárás K-vitamin-függż fehérjék elżállítására
ATE450635T1 (de) Elektrochemische herstellung von peroxo- dischwefelsäure unter einsatz von diamantbeschichteten elektroden
Fox et al. Identification of potential activators of proteinase‐activated receptor‐2 1
IL150168A0 (en) Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods bsed thereon
BR0009362A (pt) Variante de uma alfa-amilase semelhante atermamyl precursora, construção de dna, vetorde expressão recombinante, célula, composição,processo para gerar uma variante de umaalfa-amilase semelhante a termamyl precursora,e, uso de uma variante de alfa-amilase
WO2001016285A3 (en) Novel proteases and variants thereof
ATE498011T1 (de) Modifizierte embryonale stammzellen und embryonales stammzellspezifisches gen
ATE437652T1 (de) Verwendung von hmgb1 zur aktivierung dendritischer zellen
DE602005011486D1 (de) Säure-pilzprotease bei der fermentation von nichtlöslichen stärkesubstraten
HUP0301356A2 (hu) Új, DPPIV-gyel rokon szerin proteáz gének
DE59903410D1 (de) Hybridprotein zur hemmung der mastzelldegranulation und dessen verwendung
DK1266011T3 (da) Svampetranskriptionsaktivator, der er anvendelig i fremgangsmåder til fremstilling af polypeptider
ATE430807T1 (de) Verfahren zur kultivierung von circovirus
ATE474926T1 (de) Verwendung von clya hemolysin fur ausscheidung von fusionprotein
MXPA03005548A (es) Metodos para la produccion de proteinas multimericas, y composiciones relacionadas.
DK1117798T3 (da) Fungal transskriptionel aktivator egnet ved fremgangsmåder til produktion af polypeptider
DE60123074D1 (de) Modulation von gamma-secretase aktivität
WO2004011637A3 (en) Modified adamts4 molecules and method of use thereof
DK0866848T3 (da) Forbedrede neurospora-værter til fremstilling af rekombinante proteiner og fremgangsmåde til fremstilling af samme
TR200000288T2 (tr) İnsülin C-peptidin rekombinan ekspresyonu.
DE60235985D1 (de) Ntb-a, ein oberflächenmolekül impliziert in der aktivität natürlicher killerzellen (nk)
WO2003021265A8 (en) Genetic construct intracellular monitoring system
ATE320485T1 (de) Mutierte furin polypeptide, welche verbesserte eigenschaften aufweisen
ATE415487T1 (de) Biologisches testverfahren für thyroid stimulierende antikörper

Legal Events

Date Code Title Description
8363 Opposition against the patent